Stock Groups

Bavarian Nordic raises sales guidance after monkeypox vaccine order -Breaking

[ad_1]

© Reuters. FILE PHOTO A Bavarian Nordic employee works in the laboratory in Martinsried, near Munich, Germany. May 24, 2022. This Danish-based company is the first to be approved for smallpox vaccines.

COPENHAGEN, (Reuters) – Danish biotechnology company Bavarian Nordic has lifted its sales outlook. It now anticipates a lower operating loss for this year due to a deal with an unidentified country that will supply its monkeypox vaccination.

[ad_2]